Please ensure Javascript is enabled for purposes of website accessibility
Viking Therapeutics Stock Quote

Viking Therapeutics (NASDAQ: VKTX)

Price as of June 9, 2023, 4:00 p.m. ET

You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Viking Therapeutics Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
VKTX +978.67% +148.16% +19.91% +171%
S&P +2.57% +53.56% +8.96% +104%

Viking Therapeutics Company Info

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

News & Analysis

The Fool has written over 100 articles on Viking Therapeutics.


Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.